Total Payments
$4,096
2023 Payments
$39.20
Companies
32
Transactions
141
Medicare Patients
1,940
Medicare Billing
$423,365
Payment Breakdown by Category
Food & Beverage$2,248 (54.9%)
Consulting$1,560 (38.1%)
Education$138.24 (3.4%)
Gifts$118.80 (2.9%)
Travel$31.03 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,248 | 127 | 54.9% |
| Consulting Fee | $1,560 | 1 | 38.1% |
| Education | $138.24 | 10 | 3.4% |
| Gift | $118.80 | 2 | 2.9% |
| Travel and Lodging | $31.03 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,099 | 32 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $289.27 | 10 | $0 (2018) |
| MannKind Corporation | $256.43 | 7 | $0 (2021) |
| Amgen Inc. | $217.91 | 17 | $0 (2019) |
| Lilly USA, LLC | $212.05 | 17 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $196.15 | 7 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $184.68 | 8 | $0 (2019) |
| Medtronic MiniMed, Inc. | $63.33 | 4 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $55.96 | 2 | $0 (2018) |
| Shire North American Group Inc | $51.58 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $39.20 | 1 | Novo Nordisk Inc ($39.20) |
| 2021 | $97.70 | 2 | MannKind Corporation ($82.29) |
| 2020 | $49.26 | 2 | Novo Nordisk Inc ($32.27) |
| 2019 | $247.12 | 11 | Novo Nordisk Inc ($108.30) |
| 2018 | $921.79 | 65 | Amgen Inc. ($177.97) |
| 2017 | $2,741 | 60 | Novo Nordisk Inc ($1,794) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2023 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $39.20 | General |
| Category: Growth Hormone | ||||||
| 10/21/2021 | Masimo Corporation | Patient SafetyNet System (Device) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Devices | ||||||
| 08/27/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $82.29 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/01/2020 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 01/13/2020 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2019 | Novo Nordisk Inc | Victoza (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 08/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 04/26/2019 | SANOFI-AVENTIS U.S. LLC | DIABETES - DISEASE (Drug) | Food and Beverage | In-kind items and services | $89.62 | General |
| 04/09/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: VACCINE | ||||||
| 04/04/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Diabetes | ||||||
| 03/28/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Bone Health | ||||||
| 03/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Diabetes | ||||||
| 03/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Diabetes | ||||||
| 02/04/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Obesity | ||||||
| 01/17/2019 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/17/2019 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/13/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Endocrinology | ||||||
| 11/19/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Endocrinology | ||||||
| 11/08/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Diabetes | ||||||
| 10/23/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: Diabetes | ||||||
| 10/18/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Diabetes | ||||||
| 10/16/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Endocrinology | ||||||
| 10/15/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 506 | 8,689 | $377,703 | $135,188 |
| 2022 | 11 | 516 | 3,079 | $267,573 | $90,486 |
| 2021 | 15 | 505 | 7,196 | $290,517 | $105,767 |
| 2020 | 14 | 413 | 7,700 | $251,135 | $91,924 |
Total Patients
1,940
Total Services
26,664
Medicare Billing
$423,365
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 12 | 5,880 | $101,430 | $46,732 | 46.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 33 | 2,160 | $71,445 | $39,982 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 242 | $89,322 | $20,631 | 23.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 74 | 74 | $47,041 | $11,284 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 74 | $38,343 | $9,364 | 24.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 49 | 78 | $14,389 | $3,110 | 21.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 34 | 70 | $8,407 | $1,797 | 21.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 83 | $5,208 | $910.20 | 17.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 12 | $1,247 | $898.60 | 72.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 16 | $872.00 | $478.56 | 54.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 33 | 2,400 | $70,200 | $40,974 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 221 | $76,912 | $18,970 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 70 | 70 | $42,266 | $11,233 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 73 | $35,774 | $9,833 | 27.5% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2022 | 72 | 124 | $22,382 | $4,764 | 21.3% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 14 | 14 | $6,895 | $1,565 | 22.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 31 | 51 | $5,954 | $1,335 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 47 | 66 | $4,142 | $745.42 | 18.0% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2022 | 11 | 11 | $1,986 | $518.86 | 26.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $722.50 | $411.54 | 57.0% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 22 | 35 | $341.25 | $136.11 | 39.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2021 | 11 | 4,830 | $83,318 | $35,147 | 42.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 25 | 1,680 | $48,015 | $27,924 | 58.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 247 | $77,507 | $22,125 | 28.5% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2021 | 73 | 125 | $22,563 | $5,228 | 23.2% |
About Dr. Augustine Obi, M.D
Dr. Augustine Obi, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Salisbury, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093719528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Augustine Obi, M.D has received a total of $4,096 in payments from pharmaceutical and medical device companies, with $39.20 received in 2023. These payments were reported across 141 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,248).
As a Medicare-enrolled provider, Obi has provided services to 1,940 Medicare beneficiaries, totaling 26,664 services with total Medicare billing of $423,365. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Salisbury, NC
- Active Since 06/13/2005
- Last Updated 03/17/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1093719528
Products in Payments
- Victoza (Drug) $1,812
- AFREZZA (Drug) $256.43
- INVOKANA (Drug) $175.38
- TRULICITY (Drug) $167.49
- Ozempic (Drug) $137.92
- ONGLYZA (Drug) $126.10
- Prolia (Biological) $120.67
- XARELTO (Drug) $115.00
- DIABETES - DISEASE (Drug) $89.62
- CYCLOSET (Drug) $74.43
- FARXIGA (Drug) $70.05
- Minimed 670G System (Device) $63.33
- TOUJEO (Drug) $59.46
- JARDIANCE (Drug) $59.17
- NATPARA (Drug) $51.58
- Omnipod (Device) $45.38
- Repatha (Biological) $44.92
- Korlym (Drug) $39.90
- Sogroya (Biological) $39.20
- Xultophy 100/3.6 (Drug) $32.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Salisbury
Jack Snitzer, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $41,238
Endocrinology, Diabetes & Metabolism $41,238
Dr. Carey Robar, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $81.49
Endocrinology, Diabetes & Metabolism $81.49
Dr. Michael Sollenberger, Md, MD
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism